Go to deals
Healthcare | Private Equity

Science Care has received investment from American Capital Equity

The private shareholders of Science Care have sold the company to American Capital Equity Management LLC for an undisclosed consideration.

Science Care is the world’s largest non-transplant human tissue (NTHT) bank. Headquartered in Phoenix, Arizona, with facilities in California, Colorado, Florida, and Pennsylvania, Science Care provides medical device companies, medical schools and hospitals with NTHT services for training and research purposes. Science Care sources tissue through voluntary whole body donation programs, prepares tissue specimens based on customer demand and specifications, and transports tissue to its domestic and international client base.

Based in Bethesda, Maryland, American Capital Equity Management is a private equity firm specializing in investments in leveraged buy-outs. The firm focuses in middle-market investments in North America. Operating as a subsidiary of American Capital, Ltd, American Capital Equity seeks to invest between US$25–150 million in companies with an EBITDA of US$5–25 million for new platforms but it does not have any minimum for add-ons. The firm seeks to invest in companies with asset-light business models with strong free cash flow conversion. It prefers to take control equity positions but with significant management ownership post close.

Oaklins' team in Los Angeles advised the seller in this transaction.

Parties

Talk to the deal team

Jeremiah Mann

Managing Director
Los Angeles, United States
Oaklins Intrepid

James Freedman

Managing Partner
Los Angeles, United States
Oaklins Intrepid

Related deals

Valmiermuižas Alus has been acquired by Cēsu Alus
Private Equity | Food & Beverage

Valmiermuižas Alus has been acquired by Cēsu Alus

Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.

Learn more
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more
Capsol has been acquired by Angus Capital
Private Equity | Construction & Engineering Services

Capsol has been acquired by Angus Capital

Capsol has been acquired by Angus Capital as part of its strategy to build a leading construction services group alongside other portfolio companies. This partnership marks a new phase of growth for Capsol, providing the platform, resources and strategic support needed to accelerate its development and expand its market presence.

Learn more